Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Tissues

Tissues

Cells with similar structure and function are grouped into tissues. A group of tissues with a specialized function is called an organ. There are four main types of tissue in vertebrates: epithelial, connective, muscle, and nervous.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ethical Architecture and Scientific Partnership: The Enduring Role of the Laboratory Animal Veterinarian.

Journal of the American Association for Laboratory Animal Science : JAALAS·2026

Same author

Autologous Cancer Vaccines: A Precision Immunotherapy Strategy for Veterinary Cancer Patients.

Anticancer research·2025

Same author

Evaluation of Transport Time on Stress Biomarkers in Pigs.

Veterinary medicine and science·2025

Same author

AALAS Journal Updates for Authors.

Comparative medicine·2025

Same author

Protection of Rabbits Against Colonization and Morbidity Associated With Toxigenic <i>Pasteurella multocida</i> by Immunization With Inactivated Heat-labile Toxin.

In vivo (Athens, Greece)·2024

Same author

The ARRIVE 2.0 Guidelines: Importance and Full Adoption by AALAS Journals.

Comparative medicine·2024

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Tissue vaccines for cancer.

Mark A Suckow¹, Julie Heinrich, Elliot D Rosen

¹University of Notre Dame, Freimann Life Science Center, Notre Dame, IN, USA. suckow.1@nd.edu

Expert Review of Vaccines

|April 2, 2008

Summary

Tissue vaccines, harvested directly from tumors, offer a more comprehensive approach to cancer treatment than traditional single-antigen vaccines. They include diverse antigens from both cancer cells and the tumor microenvironment, potentially enhancing immune response.

Area of Science:

Oncology
Immunology
Biotechnology

Background:

Tumors, such as prostate carcinoma, are complex and heterogeneous, comprising neoplastic cells and stromal matrix.
Conventional cancer vaccines often use single antigens or cultured cell lines, which may not accurately represent the in vivo tumor.
Neoplastic cells cultured in vitro can exhibit significant differences compared to those within the tumor microenvironment.

Purpose of the Study:

To evaluate the potential utility of tissue vaccines for cancer treatment.
To highlight the advantages of using whole-tissue preparations over single-antigen or cultured-cell vaccines.

Main Methods:

Harvesting tissue directly from tumors to create vaccines.
Utilizing the inherent heterogeneity of tumor tissue, including neoplastic cells and stromal matrix, for vaccine preparation.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Related Experiment Videos

Last Updated: Jul 6, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Main Results:

Tissue vaccines are antigenically rich, containing both neoplastic cells and supporting stromal matrix.
These vaccines incorporate antigens expressed in vivo, which may be crucial for effective anti-cancer immunity.
Cultured neoplastic cells show significant divergence from in vivo profiles, limiting the efficacy of traditional whole-cell vaccines.

Conclusions:

Tissue vaccines possess significant potential for cancer treatment due to their comprehensive antigenic profile.
Further exploration of tissue vaccines is warranted given their ability to capture in vivo-specific antigens.
Tissue vaccines represent a promising strategy for enhancing anti-cancer immune responses.